2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1337):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-157180
    WAY-327131
    		≥98.0%
    WAY-327131 is an active molecule.
    WAY-327131
  • HY-U00204
    Nisobamate
    Nisobamate (W1015) is a tranquilizer.
    Nisobamate
  • HY-U00358
    Compound 2
    Compound 2 is an active compound used for the research of metabolic bone diseases.
    Compound 2
  • HY-U00020
    AU-224
    AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
    AU-224
  • HY-U00127
    Pyridazinediones-derivative-1
    Pyridazinediones-derivative-1 has potential in treating neurodegenerative disorders. It shows an ED50 of 2.1 μM for inhibiting glutamate-induced contractions of isolated guineapig ileum.
    Pyridazinediones-derivative-1
  • HY-U00059
    Pyrrole-derivative1
    Pyrrole-derivative1 is extracted from patent WO/2002/085851A1, example 2, developed for the treatment of diabetic disease.
    Pyrrole-derivative1
  • HY-W016704
    2,5-Dihydroxybenzoic acid sodium
    2,5-Dihydroxybenzoic acid (sodium) (Gentisic acid (sodium)) is a phenolic compound. 2,5-Dihydroxybenzoic acid (sodium) restores mean arterial pressure and reduces blood lactate concentration in animal models of sepsis and septic shock. 2,5-Dihydroxybenzoic acid (sodium) can be used in the study of septic shock related diseases.
    2,5-Dihydroxybenzoic acid sodium
  • HY-U00332
    Hydrocarbon chain derivative 1
    Hydrocarbon chain derivative 1 is an active compound, with inhibitory activities against lipid synthesis.
    Hydrocarbon chain derivative 1
  • HY-U00409
    Antiasthmatic Compound 1
    Antiasthmatic Compound 1 is an antiasthmatic agent, which has the potential for allergic asthma treatment.
    Antiasthmatic Compound 1
  • HY-U00378
    Glycerol derivative 1
    Glycerol derivative 1 is a Glycerol derivative extracted from patent EP 672415 A1, compound (1).
    Glycerol derivative 1
  • HY-U00278
    Deloxolone
    Deloxolone has the potential for inflammatory, ischemic and proliferative diseases treatment.
    Deloxolone
  • HY-U00301
    Anti-hypertensive sulfonanilide 1
    Anti-hypertensive sulfonanilide 1 is a potent antihypertensive agent extracted from patent EP0338793A2, compound XVIIIa,b*, example No.1.
    Anti-hypertensive sulfonanilide 1
  • HY-U00109
    Piridocaine hydrochloride
    Piridocaine hydrochloride (Lucaine hydrochloride) is a piperidyl propanol ester of orthoaminobenzoic acid.
    Piridocaine hydrochloride
  • HY-U00122
    Antiulcer Agent 1
    Antiulcer Agent 1 is a 2-(3,4-dimethoxyphenyl)ethylamine derivative for oral administration at an exploratory stage of new agent development.
    Antiulcer Agent 1
  • HY-U00323
    Carbazole derivative 1
    Carbazole derivative 1 is a carbazole derivative which can be used to reduce androgen or oestrogen levels in mammals, including humans.
    Carbazole derivative 1
  • HY-U00357
    Urinary Incontinence-Targeting Compound 1
    Urinary Incontinence-Targeting Compound 1 is a sulfonanilide derivative, used in the research of urinary incontinence.
    Urinary Incontinence-Targeting Compound 1
  • HY-101831
    Heterocyclyl carbamate derivative 1
    Heterocyclyl carbamate derivative 1 is a heterocyclyl carbamate derivative that may be used for the research of inflammatory and neurological diseases.
    Heterocyclyl carbamate derivative 1